# OnCo record nct07155226 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07155226/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07155226", "NCT07155226" ;
  schema:name "Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression"@en ;
  schema:description "A phase 1/2 trial of AZD3632 in acute lymphoblastic leukaemia, acute myeloid leukaemia and myelodysplastic syndromes / neoplasms, run by AstraZeneca, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07155226/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07155226> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2026-01-09" ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/mds/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/> .